BioSpace News Archive

Business

CSI Laboratories Begins Offering VENTANA PD-L1 (SP142) Assay as Companion Diagnostic Test for Triple Negative Breast Cancer as a Result of FDA Approval for TENCENTRIQ® (atezolizumab)

CSI Laboratories, a nationally renowned laboratory specializing in comprehensive cancer diagnostics, announced that it has added the newly approved VENTANA PD-L1 Assay as a companion diagnostic test for use in selecting triple-negative breast cancer patients for TENCENTRIQ®.

March 18, 2019
·
2 min read
Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference

Novocure announced that Wilco Groenhuysen, Novocure’s Chief Financial Officer, will participate in Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019, in New York City.

March 18, 2019
·
3 min read
Business

Advancing Eyecare Announces Appointment of Brad Staley as Chief Executive Officer

Experienced CEO with Global Operating Expertise to Oversee Lombart Instrument, Marco Ophthalmic, INNOVA Medical Ophthalmics, and Enhanced Medical Services

March 18, 2019
·
4 min read
Business

Harvest One Announces Supply Agreement with Shoppers Drug Mart

Harvest One Cannabis Inc., through it’s wholly-owned subsidiary United Greeneries Ltd. announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.

March 18, 2019
·
3 min read
BioMidwest

Home State Health Partners With Kids Vision for Life St. Louis To Provide Vision Screenings To Lucas Crossing Elementary School

In partnership with Kids Vision for Life St. Louis, Home State Health recently provided vision screenings for 600 students of Lucas Crossing Elementary school in the Normandy Schools Collaborative.

March 18, 2019
·
2 min read
Job Trends

Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

Soliton, Inc. has been invited to present at Oppenheimer’s 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at The Westin New York Grand Central in New York City.

March 18, 2019
·
3 min read
FDA

Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD

Systemic sclerosis (SSc), also known as scleroderma, is a rare chronic connective tissue disease

March 18, 2019
·
6 min read
Deals

Henry Schein Acquires Lighthouse 360 From Web.com

Addition of highly regarded software tools within Henry Schein One furthers mission of simplifying dental practice management via one integrated technology platform

March 18, 2019
·
8 min read
Business

BlueRock Therapeutics Appoints Joachim Fruebis, Ph.D., as Chief Development Officer

Strengthens executive team with drug development expertise to translate novel Cell+Gene platform into therapeutic programs

March 18, 2019
·
3 min read
BioCapital

Know Diabetes by Heart™ Expands to Include Quality Improvement Programs to Address Gaps in Type 2 Diabetes Care

Landmark initiative supports health care providers in educating people living with type 2 diabetes within health care systems

March 18, 2019
·
7 min read